GoodwinGoodwin

Goodwin + KPMG 7th Annual Symposium @ JP Morgan Healthcare Conference 2026

Pipette in a petri dish

Goodwin and KPMG will host our 7th Annual Symposium held during the 44th Annual J.P. Morgan Healthcare Conference week.

Transactions to Transformations in Life Sciences of the Future

In today’s market, M&A and strategic transactions are increasingly critical to sustaining innovation and fueling growth for life sciences companies. This year’s symposium will spotlight how industry leaders are leveraging dealmaking—not just as a response to capital constraints, but as a catalyst to advance pipelines, strengthen balance sheets, and position for long-term success.

Through candid discussions and actionable insights, we’ll explore both the art and the mechanics of end-to-end M&A, where the integration of the target is just as important as initial target diligence, the evolving financing landscape, creative partnering strategies, and the role of consolidation in shaping the next era of life sciences.

Featured Insights

How the Trump Administration Could Reshape Regulation in the Life Sciences Sector

Six areas in which emerging policy suggest significant changes for biotech, pharmaceutical, and medical device companies.

Life Sciences M&A Boom and Other Trends to Watch in 2025

Learn more about significant developments expected for the life sciences sector in 2025.

Six Hot Trends in Life Sciences for 2025

See what to expect when it comes to investor interest, AI, and more.

2025 Agenda

  • Rachael Bushey, Life Sciences Partner, Co-Chair, Philadelphia Office, Goodwin
  • Kristin Ciriello Pothier, US LS Sector Leader, Global Deal Advisory & Strategy HCLS Leader, KPMG

  • Beni Surpin, Life Sciences Partner, Goodwin
  • Joe Zaccaria, Managing Director, Healthcare & Life Sciences (HCLS), KPMG
  • Dan Caron, Chief Executive Officer, Health Universe
  • Maria Luisa Pineda, Co-Founder and CEO, Envisagenics
  • Enes Hoşgör, Ph.D., CEO & Founder, Gesund.AI
  • Lindsay Mateo, CCO, Weave

  • Danielle Lauzon, Life Sciences Partner, Co-Chair of Life Sciences M&A, Goodwin
  • Michael Buchanio, Managing Director - Deal Advisory & Strategy, KPMG
  • Marla Dubinsky, MD, CEO and Co-Founder, Trellus Health Inc.
  • Jonathan Bush, CEO, Zus Health
  • Reena Pande, MD, Partner, Oxeon

  • Chris Wilson, Partner, Co-Chair, Healthcare, Goodwin
  • Ross Nelson, Principal, National Healthcare Strategy Leader, KPMG
  • Mehran Ahmed, Partner, InTandem Capital
  • Ran Zheng, CEO, Landmark Bio

  • Sophie McGrath, Partner, Goodwin
  • Jason Moran, Managing Director, Healthcare Life Sciences, KPMG
  • Bali Muralidhar, Managing Partner, Chief Investment Officer & COO, Abingworth
  • Ari Brettman, M.D., Sr. Managing Director, Blackstone Life Sciences
  • Amit Sinha, Partner, Global Head of Life Sciences Investing, Goldman Sachs & Co. LLC

  • Stuart Cable, Vice-Chair and Global Head of M&A, Goodwin
  • E. Eric Tokat, Co-President of Investment Banking, Centerview Partners

  • Arman Oruc, Partner, Co-Chair, Antitrust + Competition, Goodwin
  • Matt Wetzel, Partner, Life Sciences Regulatory & Compliance Goodwin
  • Julie Tibbets, Partner, Chair, Life Sciences Regulatory & Compliance Practice, Goodwin

  • Noelle Dubiansky, Partner, Goodwin
  • Kristin Ciriello Pothier, US LS Sector Leader, Global Deal Advisory & Strategy HCLS Leader, KPMG
  • Daniel Rosan, Chief Financial and Business Officer, Ascidian Therapeutics
  • Karen Madden, Chief Technology Officer, MilliporeSigma
  • Scott Carter, Associate General Counsel and Head of Business Development Legal, BeiGene USA, Inc.
  • Chrissy Finkel, VP of M&A, Baxter

  • Rob Masella, Partner, Co-Chair, Public M&A, Goodwin
  • Steve Sapletal, Principal, National Advisory Leader, Life Sciences, KPMG
  • David Kitterick, Managing Partner, Morgan Stanley
  • Steve Walker, Sr Director, Alliance Management and M&A Integration, Eli Lilly and Company
  • Soumya (SDR) Dutta Roy, Vice President, Global Integration, Baxter Healthcare Corporation

  • Kalli Dircks, Managing Director & Co-Head of Healthcare ECM, Morgan Stanley

  • Jennifer Porter, Partner, Goodwin
  • Shari Mager, Partner, KPMG
  • David Haber, Managing Director, Investment Banking Division; Morgan Stanley
  • Brad Dahms, Chief Financial Officer and Chief Business Officer, IDRx, Inc.

  • Lisa Haddad, Partner, Goodwin
  • Bill Anderson, Senior Managing Director and Global Head of Strategic M&A, Defense, & Shareholder Advisory, Evercore

  • Rachael Bushey, Life Sciences Partner, Co-Chair, Philadelphia Office, Goodwin
  • Kristin Ciriello Pothier, US LS Sector Leader, Global Deal Advisory & Strategy HCLS Leader, KPMG

Previous Years

2024 Goodwin + KPMG 5th Annual Symposium @ JP Morgan

Browse the 2024 agenda and speaker list, and watch videos from the event.

2023 Goodwin + KPMG 4th Annual Symposium @ JP Morgan

Browse the 2023 agenda and speaker list, and watch videos from the event.

Learn More about Life Sciences at Goodwin

Life Sciences Practice

Our Life Sciences practice is uniquely positioned to partner with innovators and investors operating in a fast-moving, technology-driven environment. We work with life sciences companies throughout the corporate lifecycle, as well as with investors, banks, and others in the life sciences ecosystem.

Life Sciences Perspectives Blog

Our Life Sciences Perspectives blog is a resource specifically aimed at addressing your most frequent and pressing issues in this dynamic industry. We provide the insights you need most, including developments on private and public company matters, licensing deals and collaborations, patent and IP matters, FDA and healthcare regulatory compliance, and European and Asian developments for life sciences companies.

Get In Touch

For more information about our annual Symposium, please email jpm@goodwinlaw.com.

Related Content & Attendees

See More
Subscribe For Updates
Copyright © 2025 Goodwin Procter LLP